#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pelizaeus-Merzbacher disease Neurotrophic keratopathy Infertility male Hereditary optic atrophy Plasma cell myeloma recurrent Castleman's disease Cystic fibrosis respiratory infection suppression Plasma cell myeloma Meningitis meningococcal Infection in an immunocompromised host Paraganglion neoplasm Small cell lung cancer extensive stage Chronic kidney disease Hypersomnia Hodgkin's disease recurrent More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Basic Information Myelodysplastic syndrome Glycogen storage disease type V – Diagnostics Lymphangiosarcoma – Basic Information Progressive supranuclear palsy – Diagnostics Mitochondrial myopathy – Diagnostics Haemophilia A with anti factor VIII – Treatment Shprintzen-Goldberg syndrome Paroxysmal nocturnal haemoglobinuria – Basic Information VEXAS syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epirubicin Hydrochloride Technetium (99Mtc) Magnesium Oxide, Light Carisbamate IPN01195 Kk8123 Misoprostol Etelcalcetide Fludrocortisone R-Azasetron Besilate Ianalumab Rmc-6291 Haloperidol Decanoate CAMOSTAT MESILATE Sodium Nitroprusside Dihydrate Talquetamab Abbv-668 Afm24 Arachis Hypogaea Flour Tazobactam More therapies…

    Learn about Your Condition

    Intestinal ischaemia Primary hypogonadism Muscle injury Metastases to rectum Alcoholic liver disease Angiosarcoma Primary hypercholesterolaemia Pulmonary fibrosis Asthmatic crisis Cutaneous lupus erythematosus Irritable bowel syndrome Carpal tunnel syndrome Pyelonephritis acute Contusion Critical illness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of 5% Potassium Hydroxide Solution for Treating Mild to Moderate Actinic Keratosis in Adults

    Recruiting

    3 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • POTASSIUM HYDROXIDE
    Germany

  • Study Comparing Doravirine/Lamivudine and Dolutegravir/Lamivudine for HIV Patients with Controlled Viral Load on Three-Drug Regimens

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dolutegravir
    • Doravirine
    • Lamivudine
    France

  • A Study of Trastuzumab Deruxtecan Treatment for Patients with Early-Stage HER2-Positive or HER2-Low Breast Cancer Who Show Signs of Molecular Relapse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • HER2 positive breast cancer
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Germany

  • Evaluation of Cemiplimab Safety and Effectiveness as First Treatment for Advanced Basal Cell Carcinoma in Adult Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cemiplimab
    Germany

  • Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Atrial fibrillation
    • Cardiac failure
    Investigated Drugs:
    • Allopurinol
    Poland

  • Study of Roginolisib for Patients with Advanced Uveal Melanoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Roginolisib
    • Relatlimab
    • Dacarbazine Citrate
    Italy Spain
Previous Page
1 … 261 262 263 264 265 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!